[HTML][HTML] Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment

FM Guerra, LC Rosella, S Dunn, SE Wilson, C Chen… - Vaccine, 2016 - Elsevier
Introduction This study aimed to evaluate the early population impact of Ontario's school-
based human papillomavirus (HPV) vaccination program, implemented in September 2007 …

Genital wart recurrence among men residing in Brazil, Mexico, and the United States

AR Giuliano, B Sirak, M Abrahamsen… - The Journal of …, 2019 - academic.oup.com
Background Genital wart (GW) incidence is high among men. The percentage and rate at
which subsequent GW events occur are understudied. The purpose of this study was to …

[HTML][HTML] Sex differences in the prevalence and determinants of HPV-related external genital lesions in young adults: a national cross-sectional survey in Brazil

J Comerlato, NL Kops, M Bessel, JD Horvath… - BMC Infectious …, 2020 - Springer
Background External genital lesions (EGL) are the most common sexually transmitted
infections (STIs). We aimed to evaluate the prevalence, determinants and sex differences in …

[HTML][HTML] The Burden of Genital Warts in Finland: Cross-Sectional Analysis of the Prevalence and Direct Medical Costs in 2018

A Gylling, K Uusi-Rauva, I Toppila, E Hiltunen-Back - Vaccines, 2023 - mdpi.com
Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health
problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used …

Burden of genital warts in Peru: an observational study

PJ García, CP Carcamo… - … journal of STD & …, 2019 - journals.sagepub.com
Genital warts (GW) are mucosal or skin lesions caused by sexual transmission of human
papillomavirus (HPV). This study estimates the frequency of GW cases in physicians' clinics …

Impact populationnel de l'adoption d'un calendrier mixte de vaccination contre les virus du papillome humain au Québec: une étude de modélisation

É Racine - 2020 - corpus.ulaval.ca
Résumé En 2018, la province de Québec a modifié son calendrier de vaccination contre les
virus du papillome humain (VPH), remplaçant le calendrier comportant 2 doses de vaccin …